These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 3305319)
1. Drug-induced tolerance to allografts in mice. X. Augmentation of split tolerance in murine combinations disparate at both H-2 and non-H-2 antigens by the use of spleen cells from donors preimmunized with recipient antigens. Mayumi H; Himeno K; Tokuda N; Fan JL; Nomoto K Immunobiology; 1987 May; 174(3):274-91. PubMed ID: 3305319 [TBL] [Abstract][Full Text] [Related]
2. Induction of tolerance across major barriers using a two-step method with genetic analysis of tolerance induction. Mayumi H; Good RA Immunobiology; 1989 Mar; 179(1):86-108. PubMed ID: 2659501 [TBL] [Abstract][Full Text] [Related]
3. The necessity of both allogeneic antigens and stem cells for cyclophosphamide-induced skin allograft tolerance in mice. Mayumi H; Good RA Immunobiology; 1989 Feb; 178(4-5):287-304. PubMed ID: 2565882 [TBL] [Abstract][Full Text] [Related]
4. Importance of suppressor T cells in cyclophosphamide-induced tolerance to the non-H-2-encoded alloantigens. Is mixed chimerism really required in maintaining a skin allograft tolerance? Tomita Y; Mayumi H; Eto M; Nomoto K J Immunol; 1990 Jan; 144(2):463-73. PubMed ID: 2136891 [TBL] [Abstract][Full Text] [Related]
5. Establishment of a novel method to induce tolerance in adult mice across fully allogeneic (entire H-2 plus multiminor histocompatibility) antigen barriers, using supralethal irradiation followed by injection of syngeneic bone marrow cells plus (donor X recipient) F1 spleen cells. Tomita Y; Himeno K; Mayumi H; Tokuda N; Nomoto K Immunobiology; 1989 Jun; 179(2-3):214-29. PubMed ID: 2793203 [TBL] [Abstract][Full Text] [Related]
6. Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide. Mayumi H; Good RA J Exp Med; 1989 Jan; 169(1):213-38. PubMed ID: 2642528 [TBL] [Abstract][Full Text] [Related]
7. Specific destruction of host-reactive mature T cells of donor origin prevents graft-versus-host disease in cyclophosphamide-induced tolerant mice. Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Maeda T; Ando T; Nomoto K J Immunol; 1991 Mar; 146(5):1402-9. PubMed ID: 1671578 [TBL] [Abstract][Full Text] [Related]
8. Requirement of a higher degree of chimerism for skin allograft tolerance in cyclophosphamide-induced tolerance. Iwai T; Tomita Y; Zhang QW; Shimizu I; Nomoto K; Yasui H Transpl Int; 2005 May; 17(12):795-803. PubMed ID: 15856178 [TBL] [Abstract][Full Text] [Related]
9. Recombinant human granulocyte colony-stimulating factor improves the compromised state of recipient mice without affecting the induction of specific tolerance in the cyclophosphamide-induced tolerance system. Nishimura Y; Mayumi H; Tomita Y; Eto M; Maeda T; Nomoto K J Immunol; 1991 Apr; 146(8):2639-47. PubMed ID: 1707914 [TBL] [Abstract][Full Text] [Related]
10. Inability of cyclophosphamide-induced tolerance to permit engraftment of pluripotent stem cells contained in a moderate number of syngeneic bone marrow cells. Yoshikawa M; Tomita Y; Uchida T; Zhang QW; Nomoto K Immunobiology; 2000 Apr; 201(5):552-67. PubMed ID: 10834313 [TBL] [Abstract][Full Text] [Related]
11. The requirement of intrathymic mixed chimerism and clonal deletion for a long-lasting skin allograft tolerance in cyclophosphamide-induced tolerance. Eto M; Mayumi H; Tomita Y; Yoshikai Y; Nishimura Y; Nomoto K Eur J Immunol; 1990 Sep; 20(9):2005-13. PubMed ID: 2209702 [TBL] [Abstract][Full Text] [Related]
12. Anti-CD4 monoclonal antibody reduces the dose of cyclophosphamide required to induce tolerance to H-2 haplotype identical skin allografts in mice. Omoto K; Nishimura Y; Nomoto K; Kong YY; Umesue M; Murakami Y; Tomita Y; Nomoto K Immunobiology; 1996 Jan; 195(1):16-32. PubMed ID: 8852598 [TBL] [Abstract][Full Text] [Related]
13. Drug-induced tolerance to allografts in mice. IX. Establishment of complete chimerism by allogeneic spleen cell transplantation from donors made tolerant to H-2-identical recipients. Mayumi H; Himeno K; Tanaka K; Tokuda N; Fan JL; Nomoto K Transplantation; 1986 Oct; 42(4):417-22. PubMed ID: 3532453 [TBL] [Abstract][Full Text] [Related]
14. Interference with cyclophosphamide-induced skin allograft tolerance by cyclosporin A. Nomoto K; Eto M; Yanaga K; Nishimura Y; Maeda T; Nomoto K J Immunol; 1992 Oct; 149(8):2668-74. PubMed ID: 1401906 [TBL] [Abstract][Full Text] [Related]
15. The induction of skin xenograft tolerance in rat-to-mouse combination could be affected by DFR mediating cells and antibodies against rat bone marrow cells as well as NK cells in the cyclophosphamide-induced tolerance system. Nishimura Y; Eto M; Maeda T; Hiromatsu K; Nomoto K; Kong YY; Nomoto K Immunobiology; 1995 Aug; 193(5):420-38. PubMed ID: 8522358 [TBL] [Abstract][Full Text] [Related]
16. Similarity and difference in the mechanisms of neonatally induced tolerance and cyclophosphamide-induced tolerance in mice. Eto M; Mayumi H; Nishimura Y; Maeda T; Yoshikai Y; Nomoto K J Immunol; 1991 Oct; 147(8):2439-46. PubMed ID: 1918974 [TBL] [Abstract][Full Text] [Related]
17. Induction of tolerance to non-H-2 alloantigens is not restricted by the MHC molecules expressed on the donor cells in cyclophosphamide-induced tolerance. Tomita Y; Nomoto K Immunobiology; 1990 Nov; 181(4-5):430-7. PubMed ID: 2099910 [TBL] [Abstract][Full Text] [Related]
18. [Study on the improved effect of anti-TCR alpha beta monoclonal antibody on the induction of transplantation tolerance to the allogeneic skin graft in mice and its mechanisms]. Hao J; Liu J; Xie S Zhonghua Yi Xue Za Zhi; 2001 May; 81(10):593-6. PubMed ID: 11798930 [TBL] [Abstract][Full Text] [Related]
19. Drug-induced tolerance to allografts in mice. VI. Tolerance induction in H-2-haplotype-identical strain combinations in mice. Mayumi H; Himeno K; Shin T; Nomoto K Transplantation; 1985 Aug; 40(2):188-94. PubMed ID: 3895627 [TBL] [Abstract][Full Text] [Related]